EUDA Health Holdings Limited

NASDAQ:EUDA

Medical - Care Facilities

Healthcare
$17.70 +14.19%

+$2.20 today

Market cap
$53.00M
Beta
0.59
P/E (TTM)
-7.9
EPS (TTM)
-$1.79
52W Low $5.26High $71.20

Volume 0.04M

Average 0.02M

EUDA Other Financing Activities

Financing cash flows not reported separately.

EUDA Health Holdings LimitedNASDAQ: EUDA

Other Financing Activities · Q2 FY2026 · quarter ended Jun 2026

Other financing activities growth accelerates

Q2 FY2026 other financing activities of $746.83K rose 33.6% year over year, ahead of the +30.8% change in trailing-twelve-month other financing activities. Sequentially, it rose 0.0% from the prior quarter.

Context

  • Other financing activities amounted to 3.4% of revenue in FY2025, up 0.6 pp from a year earlier.
  • Other financing activities increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +33.6% holds above the trailing-twelve-month pace of +30.8%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$746.83K+0.0% QoQ
Last fiscal yearDec 2025
$234.46K+103.6% YoY
LTMJun 2026
$2.54M+30.8% YoY
Other Financing Activities past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+33.6%——
1 year+103.6%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Other Financing Activities history

USD · from the cash flow

Latest · FY2025
234.46K USD
Year-over-year change
+103.6%

Other Financing Activities vs competitors

How EUDA compares with its peers on the latest reported figures

  • Peers report in different currencies, so other financing activities is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +30.8% is the 2nd highest of 8, against a peer median of -59.8%.
  • Other financing activities amounts to 20.9% of revenue for EUDA, versus a peer median of 2.2%.
EUDA Competitors
Other Financing Activities for EUDA and competitors
Company Period LTM YoY 3-year CAGR% of revenue
FONRFONAR CorporationLTM Mar 2026$4.52M USD-16.9%-1.6%4.3%
EUDAEUDA Health Holdings LimitedLTM Jun 2026$2.54M USD+30.8%—20.9%
AMWLAmerican Well CorporationLTM Mar 2026$300K USD-87.3%—0.1%
ATYRaTyr Pharma, Inc.LTM Mar 2026$98K USD-2.0%—51.6%
ZTEKZentek Ltd.LTM Mar 2026CA$35.59K CAD-59.8%—21.4%
DTILPrecision BioSciences, Inc.LTM Mar 2026$0 USD-100.0%—0.0%
HYPRHyperfine, Inc.LTM Mar 2026$0 USD-100.0%—0.0%
GUTSFractyl Health, Inc. Common StockLTM Mar 2026$0 USD+100.0%——
Peer median (excluding EUDA) —-59.8%-1.6%2.2%

Competitors are the stored peer set for EUDA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income900.4K(24.95M)(8.44M)(17.6M)(2.77M)
Depreciation & Amortization264.1K172.02K119.35K173.22K406.48K
Deferred Income Tax(27.68K)(48.23K)0(4.38K)4.38K
Stock-Based Compensation00000
Change in Working Capital1.18M1.12M531.2K194.93K(230.03K)
Accounts Receivables(263.95K)(174.82K)(32.97K)82.35K(166.99K)
Inventory03.69M0(126.27K)45.43K
Accounts Payables1.38M(1.13M)1.27K15.99K(12.95K)
Other Working Capital68.04K(1.27M)562.89K222.86K(95.52K)
Other Non-Cash Items(1.87M)22.18M4.87M15.21M160.35K
Operating Cash Flow443.92K(1.53M)(2.92M)(2.03M)(2.43M)
Capital Expenditures(1.96K)(18.14K)(5)(116.03K)(104.45K)
Acquisitions (Net)(354.23K)(3.41K)016.3K0
Purchases of Investments00000
Sales of Investments00000
Other Investing Activities(355.08K)(246.66K)5(48.03K)(27.19K)
Investing Cash Flow(356.18K)(268.21K)0(147.77K)(104.45K)
Debt Repayment(6.69K)1.4M1.44M2.16M2.22M
Common Stock Issued01.1M790K50K100K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities(161.69K)(9.47K)121.88K115.14K234.46K
Financing Cash Flow(168.37K)2.49M2.35M2.32M2.55M
Effect of Forex Changes19.87K(99.42K)(21.53K)(101.66K)88.49K
Net Change in Cash(60.77K)594.49K(586.93K)40.05K107.54K
Free Cash Flow441.96K(1.54M)(2.92M)(2.15M)(2.53M)

EUDA Health Holdings Limited

NASDAQ:EUDA

Intrinsic Alpha fair value

Locked

Current Price

$17.70

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.